Researchers discover an unusual accumulation of particles in people with the disease; the causes are still unclear.

Merrill H. Stewart, MD, Ochsner Health, explains how his practice takes advantage of downtime during cardiologist ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

Much like cardiac rehabilitation for patients with heart disease, pulmonary rehab is a multi-domain medical intervention that incorporates education on disease, medication, behaviors, and how to ...

Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...

Hospital admissions were reduced by more than 50% in the intervention group (P < .001), highlighting the potential of structured home-based care to break the cycle of frequent exacerbations in ...

In an open-label, phase 4 pilot study, Drummond and colleagues analyzed 40 current smokers (mean age, 62.5 years; 48% women; 83% white; mean FEV 1, 46.1% predicted) with ambulatory COPD using the ...

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

COPD patients who receive intensive guidance from a hospital pharmacist during their stay use their inhalation medication more correctly and with greater confidence. This was shown in a study ...

It's difficult to overstate the corrosive impact of Canada's ongoing opioid crisis. Since 2016, there have been over 40,000 opioid-related deaths across the country, devastating Canadian families ...

New study results with GSK's anti-IL-5 antibody Nucala in chronic obstructive pulmonary disease (COPD) have been published, just ahead of an FDA decision on the new indication scheduled for 7th May.

In a statement on the approval, GSK said that a lower threshold means that nearly 70% of COPD patients in the US who are inadequately controlled on inhaled triple therapy could be eligible for Nucala.